VirtualScopics (NASDAQ:VSCP) provides imaging solutions used in drug and medical device development.
Market incorrectly assumes transition year will become a recurring event
The distressed relative valuation may appeared deserved due to the following recent headwinds.
Lack of revenue growth and profitability. The current revenue run rate is near a five year low (and projected to be unchanged for 2014) due to the slowdown in bookings in prior years that has since carried over into more recent results as well as the timing of the startup of new projects and revenue recognition. This lower top line has flowed through to the bottom line as shown in the chart below.
C-suite turnover. In the fall...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|